Anti-COVID pill developed by Merck accused of accelerating coronavirus mutations

Molnupiravir, the anti-COVID-19 pill developed by Merck, is at risk of aggravating the pandemic? Several researchers say that this treatment contributes to the emergence of mutations of the new coronavirus, with a risk that remains theoretical for now: the appearance of dangerous variants, AFP and Agerpres informs.